Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Checkpoint Inhibition before Axicabtagene Ciloleucel Cell Therapy in Primary Mediastinal B-Cell Lymphoma (PMBCL) Treated in Real Life Setting

Annalisa Chiappella, Anna Dodero, Anna Guidetti, Filippo Bagnoli, MD, Vanessa Aragona, Anna Maria Barbui, MD, Stefania Bramanti, MD, Matteo Giovanni Carrabba, MD, Federica Sorà, MD, Pierluigi Zinzani, Prof, MD, Chiara Monfrini, Cristiana Carniti, Paolo Corradini

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-140054

Published: 2020

Journal Articles

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Blood (2019) 134 (Supplement_1): 4614.

https://doi.org/10.1182/blood-2019-128004

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Armando Santoro, MD, Luca Castagna, MD, Massimo Magagnoli, MD, Stefania Bramanti, MD, Jacopo Mariotti, MD, Rita Mazza, MD, Lucia Morello, MD, Francesca Ricci, MD, Barbara Sarina, MD, Chiara De Philippis, MD, Simona Sica, MD, Marcello Rodari, MD, Martina Sollini, MD, Margarita Kirienko, MD, Laura Giordano, Arturo Chiti, MD, Paolo Corradini, MD, Carmelo Carlo-Stella, MD

Blood (2018) 132 (Supplement 1): 2185.

https://doi.org/10.1182/blood-2018-99-118127

Published: 2018

Journal Articles

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis

Chiara De Philippis, MD, Jacopo Mariotti, MD, Reda Bouabdallah, MD, Raynier Devillier, Stefania Bramanti, MD, Samia Harbi, MD, Sabine Furst, MD, Faezeh Legrand, MD, Barbara Sarina, MD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, Luca Castagna

Blood (2018) 132 (Supplement 1): 5748.

https://doi.org/10.1182/blood-2018-99-117005

Published: 2018

Journal Articles

Which Is the Best Mobilizing Regimen in POEMS Syndrome? a Retrospective Italian Study of Two Haematological Centres

Francesco Autore, MD, Nicola Piccirillo, MD, Andrea Nozza, MD, Idanna Innocenti, MD PhD, Rossana Putzulu, MD, Patrizia Chiusolo, MD, Federica Sora, MD, Gina Zini, MD PhD, Andrea Bacigalupo, MD, Luca Castagna, MD, Simona Sica, MD, Stefania Bramanti, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5692.

https://doi.org/10.1182/blood-2018-99-118554

Published: 2018

Journal Articles

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Raphaël Cauchois, Luca Castagna, MD, Samia Harbi, MD, Boris Calmels, Pharm.D., Stefania Bramanti, MD, Angela Granata, MD, Claude Lemarie, Pharm.D., Valerio Maisano, MD, Faezeh Legrand, MD, Sabine Furst, MD, Pierre Jean Weiller, MDPhD, Christian Chabannon, MD PhD, Didier Blaise, Raynier Devillier

Blood (2017) 130 (Supplement 1): 3276.

https://doi.org/10.1182/blood.V130.Suppl_1.3276.3276

Published: 2017

Journal Articles

Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation

Blood (2017) 130 (Supplement 1): 3309.

https://doi.org/10.1182/blood.V130.Suppl_1.3309.3309

Published: 2017

Journal Articles

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Samia Harbi, MD, Raynier Devillier, Stefania Bramanti, MD, Thomas Pagliardini, Faezeh Legrand, MD, Maud Cecile, Valerio Maisano, MD, Cecile Braticevic, Angela Granata, MD, Frederique Rousseau, Sabine Furst, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, pierre Jean Weiller, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 2035.

https://doi.org/10.1182/blood.V130.Suppl_1.2035.2035

Published: 2017

Journal Articles

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Jacopo Mariotti, Valerio Maisano, MD, Pierre Jean Weiller, MDPhD, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 1984.

https://doi.org/10.1182/blood.V130.Suppl_1.1984.1984

Published: 2017

Journal Articles

Severe Cytokine Release Syndrome Is a Fatal Complication after PBSC, but Not after BM Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Jacopo Mariotti, Daniela Taurino, MD, Stefania Bramanti, MD, Barbara Sarina, MD, Lucio Morabito, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Luca Castagna, MD

Blood (2017) 130 (Supplement 1): 665.

https://doi.org/10.1182/blood.V130.Suppl_1.665.665

Published: 2017

Journal Articles

The Minnesota Refined Acute GVHD Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Jacopo Mariotti, Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Barbara Sarina, MD, Sabine Furst, MD, Catherine Faucher, MD, Samia Harbi, MD, Lucio Morabito, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Reda Bouabdallah, MD, Armando Santoro, MD, Didier Blaise, Luca Castagna, MD

Blood (2017) 130 (Supplement 1): 4485.

https://doi.org/10.1182/blood.V130.Suppl_1.4485.4485

Published: 2017

Journal Articles

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Virginie Lavoipierre, Samia Harbi, MD, Luca Castagna, MD, Angela Granata, MD, Sabine Fürst, MD, Catherine Faucher, MD, Faezeh Legrand, Stefania Bramanti, MD, Christian Chabannon, MD PhD, Norbert Vey, MD PhD, Jérome Rey, Reda Bouabdallah, MD, Jean Marc Schiano De Colella, Djamel Mokart, Pierre-Jean Weiller, Prof., Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2016) 128 (22): 4618.

https://doi.org/10.1182/blood.V128.22.4618.4618

Published: 2016

Journal Articles

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Angela Granata, MD, Sabine Furst, MD, Jean marie Boher, Luca Castagna, MD, Patrice Chevallier, MD PhD, Alice Garnier, MD, Thierry Guillaume, MD PhD, Remy Dulery, MD, Mohamad Mohty, Faezeh Legrand, Samia Harbi, MD, Raynier Devillier, MD PhD, Catherine Faucher, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Boris Calmels, PharmD, PhD, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 4594.

https://doi.org/10.1182/blood.V128.22.4594.4594

Published: 2016

Journal Articles

Donor Lymphocyte Infusion after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Clemence Roux, Samia Harbi, MD, Raynier Devillier, MDPhD, Faezeh Legrand, Sabine Fürst, MD, Angela Granata, MD, Stefania Bramanti, MD, Catherine Faucher, MD, Jean ElCheikh, Djamel Mokart, Christian Chabannon, MD PhD, Boris Calmels, Pierre-Jean Weiller, Prof., Luca Castagna, MD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5863.

https://doi.org/10.1182/blood.V128.22.5863.5863

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Impact of Cytopenia Following Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophoshamide

Villetard Ferdinand, Stefania Bramanti, MD, Samia Harbi, MD, Sabine Fürst, MD, Catherine Faucher, MD, Angela Granata, MD, Faezeh Legrand, Djamel Mokart, Pierre-Jean Weiller, Prof., Christian Chabannon, MD PhD, Aude Charbonnier, Anne-Marie Stoppa, MD, Luca Castagna, MD, Didier Blaise, MD PhD, Raynier Devillier, MDPhD

Blood (2016) 128 (22): 2281.

https://doi.org/10.1182/blood.V128.22.2281.2281

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone

Roberto Crocchiolo, MD, PhD, Barbara Sarina, MD, Stefania Bramanti, MD, Lucio Morabito, MD, Andrea Rimondo, Monica Balzarotti, Massimo Magagnoli, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Luca Castagna

Blood (2015) 126 (23): 2034.

https://doi.org/10.1182/blood.V126.23.2034.2034

Published: 2015

Journal Articles

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients

Blood (2015) 126 (23): 4401.

https://doi.org/10.1182/blood.V126.23.4401.4401

Published: 2015

Journal Articles

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Luca Castagna, Stefania Bramanti, MD, Sabine Furst, Barbara Sarina, MD, Roberto Crocchiolo, MD PhD, Laura Giordano, MD, Jean El Cheikh, MD, Angela Granata, MD, Lucio Morabito, MD, Elisa Mauro, MD, Catherine Faucher, Bilal Mothy, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, MD

Blood (2014) 124 (21): 3902.

https://doi.org/10.1182/blood.V124.21.3902.3902

Published: 2014

Journal Articles

Higher Prevalence But Similar Infectious Profile Overtime After Haploidentical Transplantation Compared With HLA-Identical Transplantation For Hematological Diseases

Roberto Crocchiolo, MD, PhD, Luca Castagna, MD, Andrea Vai, Barbara Sarina, MD, Stefania Bramanti, MD, Elisa Mauro, Carmelo Carlo-Stella, MD, Armando Santoro, MD

Blood (2013) 122 (21): 4528.

https://doi.org/10.1182/blood.V122.21.4528.4528

Published: 2013

NARROW

Checkpoint Inhibition before Axicabtagene Ciloleucel Cell Therapy in Primary Mediastinal B-Cell Lymphoma (PMBCL) Treated in Real Life Setting

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis

Which Is the Best Mobilizing Regimen in POEMS Syndrome? a Retrospective Italian Study of Two Haematological Centres

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Severe Cytokine Release Syndrome Is a Fatal Complication after PBSC, but Not after BM Haploidentical Transplantation with Post-Transplant Cyclophosphamide

The Minnesota Refined Acute GVHD Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Donor Lymphocyte Infusion after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Impact of Cytopenia Following Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophoshamide

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis

Higher Prevalence But Similar Infectious Profile Overtime After Haploidentical Transplantation Compared With HLA-Identical Transplantation For Hematological Diseases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only